InsidersTradesSigma
Total declarations
Companies
▲ Purchases (444 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
444
Disclosed sells
1
T+90 hit rate
90%
T+90 mean return
+15.3%
Across 309 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Frost Phillip Md Et al. Insider active across 7 companies, notably Opko Health, INC.. Cumulatively, 462 disclosures have been recorded. Breakdown: 444 buys · 1 sell. Total volume traded: €22.2m. Activity tracked since 4 May 2021. The latest transaction was filed on 3 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Frost Phillip Md Et al
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations462 total
75,000 shares@ US$0.9412Common StockSEC:0001493152-26-036169:0
Canonical exit: 1 Nov 2026 (T+90)
20,000 shares@ US$0.99760.7% of flowCommon StockSEC:0001493152-26-008039:0
Canonical exit: 25 May 2026 (T+90)
50,000 shares@ US$0.94561.7% of flowCommon StockSEC:0001493152-26-005773:0
Canonical exit: 7 May 2026 (T+90)
50,000 shares@ US$0.94551.7% of flowCommon StockSEC:0001493152-26-000114:0
Canonical exit: 31 Mar 2026 (T+90)
20,000 shares@ US$0.96550.7% of flowCommon StockSEC:0001493152-25-029796:0
Canonical exit: 30 Mar 2026 (T+90)
25,000 shares@ US$0.97030.9% of flowCommon StockSEC:0001493152-25-029257:0
Canonical exit: 24 Mar 2026 (T+90)
1,500 shares@ US$1.000.1% of flowCommon StockSEC:0001493152-25-025314:0
Canonical exit: 24 Feb 2026 (T+90)
20,000 shares@ US$0.94060.7% of flowCommon StockSEC:0001493152-25-025048:0
Canonical exit: 23 Feb 2026 (T+90)
102,371 shares@ US$1.300.6% of flowCommon StockSEC:0001193125-25-291590:0
Canonical exit: 19 Feb 2026 (T+90)
119,129 shares@ US$1.320.7% of flowCommon StockSEC:0001193125-25-290115:0
Canonical exit: 18 Feb 2026 (T+90)
36,325 shares@ US$1.280.2% of flowCommon StockSEC:0001193125-25-288284:0
Canonical exit: 17 Feb 2026 (T+90)
410 shares@ US$1.2450.0% of flowCommon StockSEC:0001193125-25-286448:0
Canonical exit: 16 Feb 2026 (T+90)
150,000 shares@ US$1.42291.0% of flowCommon StockSEC:0001193125-25-260956:0
Canonical exit: 29 Jan 2026 (T+90)
359,713 shares@ US$1.3919.0% of flowCommon StockSEC:0001493152-25-020222:0
21,930 shares0Common StockSEC:0001104659-25-090057:0
571,429 shares@ US$0.00050.5% of flowCommon StockSEC:0001104659-25-089560:0
571,429 shares@ US$0.00050.5% of flowCommon StockSEC:0001104659-25-088314:0
440,000 shares0Common StockSEC:0000950170-25-110094:0
675,000 shares@ US$1.324.1% of flowCommon StockSEC:0000950170-25-105971:0
Canonical exit: 6 Nov 2025 (T+90)
195,852 shares@ US$1.10100.0% of flowCommon StockSEC:0001104659-25-058297:0
Canonical exit: 4 Sept 2025 (T+90)
909,297 shares@ US$0.00050.9% of flowCommon StockSEC:0001104659-25-051611:0
125,000 shares@ US$1.35770.8% of flowCommon StockSEC:0000950170-25-052925:0
Canonical exit: 9 Jul 2025 (T+90)
125,000 shares@ US$1.47720.9% of flowCommon StockSEC:0000950170-25-052214:0
Canonical exit: 7 Jul 2025 (T+90)
100,000 shares@ US$1.64850.9% of flowCommon StockSEC:0000950170-25-048737:0
Canonical exit: 30 Jun 2025 (T+90)
150,000 shares@ US$1.69591.3% of flowCommon StockSEC:0000950170-25-046952:0
Canonical exit: 26 Jun 2025 (T+90)
25 of 462 declarations
About Frost Phillip Md Et al
FROST PHILLIP MD ET AL is a declarant with 461 total filings. Across the 400 sampled recent filings, buys total EUR 22091497 and sells total EUR 51304, over the period from 2016-01-08 to 2026-02-25, and the most common transaction nature is Acquisition. The named company roles are CEO & Chairman at Opko Health, INC., Director at Cocrystal Pharma, Inc., Fluent, Inc., Director at LADENBURG THALMANN FINANCIAL SERVICES INC, Nocopi Technologies INC, and Director at IDI, Inc.
